Whalesbook
Growth Driven by Profit, but Margins Under Pressure
Dhanuka Agritech reported its fourth-quarter results for the fiscal year ending March 2026, showing net profit jumped 29.8% year-over-year to Rs 97.5 crore. This was supported by a 9.3% increase in revenue to Rs 483 crore. However, the company faced pressure on its operating margins. Earnings Before Interest, Taxes, Depreciation, and Amortisation (EBITDA) rose by a smaller 4.8% to Rs 132 crore. Consequently, the EBITDA margin compressed to 27.3% from 28.5% in the same quarter last year. This suggests revenue growth did not translate as effectively to operational earnings, possibly due to rising costs or pricing issues. On May 19, 2026, the company's stock price reflected this mixed performance, trading higher around Rs 1,131, up from its previous close, within a trading band of Rs 1,090 to Rs 1,154.9 for the day.
Valuation and Sector Comparison
The Indian agrochemical sector is projected to grow between 6% and 7% in FY26, driven by recovering exports and stable domestic demand. In this environment, Dhanuka Agritech's valuation appears attractive. Its trailing twelve-month P/E ratio is around 18.4 to 19.3, much lower than the industry average P/E of about 46.20. Compared to peers, Dhanuka trades at a lower P/E than UPL (around 22.11), PI Industries (around 32.69), and Bayer CropScience (around 29.16). It is valued similarly to Bharat Rasayan (around 17.41) and slightly higher than Sharda Cropchem (around 12.85). For context, Sharda Cropchem also reported strong Q4 FY26 results with 56.53% profit growth and higher operating margins. UPL, another major company, saw its stock fall despite revenue growth, partly due to tax issues and a 90 basis point margin decline. Dhanuka Agritech's own stock has fallen over 25% in the past year, trading between Rs 889.60 and Rs 1,975. The company's P/E ratio has varied, reaching a high of 19.62x in March 2025 and a low of 11.93x in March 2023.
Concerns Over Margin Pressure and Competition
Despite the strong net profit increase, the slowdown in EBITDA growth to 4.8% and the margin squeeze from 28.5% to 27.3% raise questions. This indicates that revenue growth is not converting into operational profit as effectively as before, possibly due to higher input costs, increased operating expenses, or intense competition. The agrochemical market is very competitive. While Dhanuka has a favourable valuation, competitors like Sharda Cropchem have shown better margin growth. The company's stock performance over the past year, with a significant drop, suggests investors are cautious. Some analysts have recently lowered their revenue and earnings per share estimates for FY26, with one projection suggesting negative revenue and profit growth for the fiscal year. The planned share buyback, while intended to reward shareholders, needs to be considered alongside the company's ability to generate cash and reinvest it effectively in a competitive market.
Analyst Views and Shareholder Returns
Looking forward, analyst opinions on Dhanuka Agritech are mixed but suggest potential for stock price increases. Average price targets are between Rs 1,194.83 and Rs 1,695.67, with some reports indicating over 50% potential upside from its recent trading price of Rs 1,083.50. However, some forecasts predict a slight year-on-year decrease in earnings per share for FY26. To reward shareholders, the company has approved a Rs 70 crore share buyback, aiming to repurchase up to 5 lakh shares at Rs 1,400 each. The record date for this buyback is May 29. Dhanuka also declared a final dividend of Rs 2 per equity share, with a record date of July 17. Company promoters intend to participate in the buyback, showing their confidence. These steps are designed to boost shareholder value, but their full effect will depend on the company successfully managing margin challenges and taking advantage of industry growth.